A group of researchers, including personnel from the University of Granada (UGR), has recently presented the results of a study into patients with systemic lupus erythematosus (SLE), a systemic autoimmune disease that carries ...
Nov 19, 2020
0
5
New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions ...
Nov 6, 2020
0
1
A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global ...
Nov 6, 2020
0
2
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged ...
Nov 6, 2020
0
3
A team of researchers from Charité–Universitätsmedizin Berlin and the Deutsches Rheuma-Forschungszentrum (DRFZ) Berlin, a Leibniz Institute, have successfully treated two patients with the autoimmune disease systemic ...
Sep 22, 2020
0
111
(HealthDay)—Some cases of subacute cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE) are drug-induced, according to a study published online Sept. 2 in JAMA Dermatology.
Sep 4, 2020
0
3
Most adults with systemic lupus erythematosus (SLE) are not at increased risk of hospitalization from COVID-19 due to medications used to dampen their altered immune system, the cause of their disease. Nor are most people ...
Aug 25, 2020
0
5
Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19.
Aug 17, 2020
0
29
A team of researchers from Children's Hospital of Philadelphia (CHOP) used a new method of pinpointing potential disease-causing changes in the genome to identify two new potential therapeutic targets for lupus, while also ...
Jul 8, 2020
0
42
(HealthDay)—A drug championed by President Donald Trump as a coronavirus panacea appears to be in short supply for people who really need it: lupus patients.
Jun 2, 2020
0
3
